(Q30475052)

7 November 2017

Determination of breast cancer response to bevacizumab therapy using contrast-enhanced ultrasound and artificial neural networks (English)

1 reference

artificial neural network

7 November 2017

1 reference

1 reference

contrast-enhanced ultrasound

1 reference

Kenneth Hoyt

1

1 reference

7 November 2017

Jason M Warram

2

1 reference

7 November 2017

Heidi Umphrey

3

1 reference

7 November 2017

Lin Belt

4

1 reference

7 November 2017

Mark E Lockhart

5

1 reference

7 November 2017

Michelle L Robbin

6

1 reference

7 November 2017

Kurt R Zinn

7

1 reference

7 November 2017

1 April 2010

1 reference

Journal of Ultrasound in Medicine

7 November 2017

1 reference

7 November 2017

29

1 reference

7 November 2017

4

1 reference

7 November 2017

577-585

1 reference

Pathways mediating resistance to vascular endothelial growth factor-targeted therapy

7 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122922

Immunohistochemistry in the evaluation of neovascularization in tumor xenografts

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122922

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122922

Antitumor effect of the angiogenesis inhibitor bevacizumab is dependent on susceptibility of tumors to hypoxia-induced apoptosis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122922

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122922

Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122922

Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122922

Computer-aided diagnosis of solid breast nodules: use of an artificial neural network based on multiple sonographic features.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122922

Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122922

Bevacizumab in the treatment of breast cancer: rationale and current data

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122922

Maximizing the potential of bevacizumab in cancer treatment

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122922

Expanding the clinical development of bevacizumab

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122922

Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122922

Contrast-enhanced US of microcirculation of superficially implanted tumors in rats.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122922

Novel artificial neural network for early detection of prostate cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122922

Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122922

Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122922

Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human p

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122922

Prediction of breast cancer malignancy using an artificial neural network

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122922

Determinants of tumor blood flow: a review

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122922

How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122922

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3122922

Optimising phase and amplitude modulation schemes for imaging microbubble contrast agents at low acoustic power

20 June 2018

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2010.29.4.577

The influence of acoustic transmit parameters on the destruction of contrast microbubbles in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2010.29.4.577

Effects of acoustic insonation parameters on ultrasound contrast agent destruction

21 January 2018

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2010.29.4.577

Prostate boundary segmentation from 2D ultrasound images.

21 January 2018

1 reference

https://api.crossref.org/works/10.7863%2FJUM.2010.29.4.577

Comparison of contrast-enhanced fundamental imaging, second-harmonic imaging, and pulse-inversion harmonic imaging

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20375376

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.7863/JUM.2010.29.4.577

1 reference

7 November 2017

1 reference

7 November 2017

PubMed publication ID

20375376

1 reference